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A large number of different kinds of substances are reported to be chemotactic 
for neutrophils (1). The size, complexity, and unknown structure of most of these 
have precluded any definitive analysis of the structural  or molecular basis of 
their  chemotactic  activity.  Recently,  Schiffmann  et  al.  have  reported  that 
simple, synthetic N-formyl methionyl peptides are chemotactic for neutrophils 
and  macrophages  (2).  This  has  made  possible the  beginning  of a  systematic 
study of the  relation  of the  structure  of simple peptides to their  chemotactic 
activity and thus,  eventually to directly investigate the primary interaction of 
chemotactic agents with the neutrophil surface. In addition to their chemotactic 
activity, substances such as C5a or low molecular weight peptides isolated from 
Escherichia coli culture filtrates induce lysosomal enzyme release from rabbit or 
human neutrophils in the presence of cytochalasin B (3, 4) or, when the neutro- 
phils are on a  suitable surface, in its absence (5, 6). 
We have synthesized a series of 24 peptides, all but 2 of them methionyl or N- 
formyl methionyl derivatives.  Most of them are di- and tripeptides,  with a few 
tetrapeptides.  We shall  show that these substances not only increase random 
movement  but  are  chemotactic  as  well,  that  is,  they  also  induce  directed 
movement. In addition, a systematic study of the relation of structure to activity 
has demonstrated a  highly specific dependence of the activity of these peptides 
upon their structure.  The ability of a given peptide to induce migration strictly 
correlates with its ability to induce lysosomal enzyme secretion from cytochal- 
asin B-treated cells suggesting that the same primary interaction of peptide and 
cell initiates both activities. 
Materials  and  Methods 
Rabbit polymorphononuclear leukocytes (neutrophils) were obtained 12-14 h after the intraper- 
itoneal injection of 0.1% glycogen, as described (7).  They were washed in Hanks' balanced salt 
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solution containing 0.01  M  tris(hydroxymethyl) aminomethane, pH 7.2,  i  mg/ml of  glucose,  and 1 
mg/ml of  crystalline  bovine serum albumin. The tris(hydroxymethyl) aminomethane and bovine 
serum albumin were obtained from Sigma Chemical Co. St. Louis, Mo. The Hanks' balanced salt 
solution  was the buffer  used throughout the work. 
Assay of Relative Migratory Activity of Peptides.  The migratory assay employed a  modified 
Boyden chamber  I  as  described previously (7).  Briefly,  1 ml  of washed peritoneal neutrophils 
containing 2.5  >  106 cells was added to the upper compartment of the modified Boyden chamber 
separated from 1 ml of peptide solution by a  25 mm diameter filter of 0.6  /~m average pore size 
(Schleicher & Schuell Inc., Keene, N. H.). The loaded chambers were incubated for 30 rain at 37°C. 
This time interval was chosen as giving, for the particular batch of filters used, the greatest 
difference between the  number  of cells moving into  the  filter with  no  peptide in  the  lower 
compartment  (background)  and  the  maximum  number  of cells  moving into  the  filter when 
stimulated by peptide. At the end of the incubation the filters were removed and stained and the 
number of cells in five high-power (400 magnification) fields (5 HPF) were counted and averaged 
(7). The results reported are the means of duplicate chambers. 
The migration enhancing activities of different peptides were compared essentially as described 
previously (8, 9). In measuring the relative activity of the peptides, a peptide was diluted so that 
each concentration was 1/4 that of the next higher concentration. The concentrations of peptides 
were  chosen on  the  basis  of preliminary experiments to  cover the  range giving minimal  to 
maximal activity. The chemotactic activity plotted against the logarithm of the molar concentra- 
tion of peptide yielded a  sigmoidal-shaped dose-response curve. Different peptides tested at the 
same time with the same cells gave curves which were parallel to each other in their linear 
portions and had the same maximum. The activities of the different peptides are reported as the 
ED.~o, the concentration of chemotactic factor giving 50%  of the maximum activity.  The  EDso 
depends on the activity of the peptide and also on the cells used in testing. In order to ensure that 
the activities determined with different cells were always comparable, a peptide, F-Met-Leu was 
arbitrarily chosen as the standard peptide and included in each assay. The activity of each peptide 
was then recorded both as the ED56 and the relative activity or potency ratio, that is the ratio of  the 
ED.~o of F-Met-Leu, run in the same experiment, to the ED.~o of the given peptide. 
Test of Whether the Peptides are Chemotactic.  The test of whether or not the peptides are truly 
chemotactic was carried out as described by Zigmond and Hirsch (10) for two peptides, F-Met-Leu- 
Phe and F-Met-Met-Met. 
In testing F-Met-Leu-Phe, 5 x  106/ml of washed peritoneal neutrophils obtained 12 h after the 
administration of 0.1%  glycogen were suspended in varying concentrations of the peptide and 
placed in the upper compartment of a modified Boyden chamber. The cells were separated from the 
bottom compartment containing varying concentrations of the same peptide by a 3.0/~m pore size 
filter (Millipore Corp., Bedford, Mass.). Duplicate chambers were incubated 60 rain at 37°C. The 
filters were fixed and processed as usual.  Using the micrometer of the fine adjustment of the 
microscope, the distance was measured from the top of the filter to the farthest plane of focus still 
containing two cells.  This  distance was determined across five fields and  averaged  (10). The 
results reported are the means of duplicate chambers. 
In testing F-Met-Met-Met, essentially the same procedure was followed except that 8 ×  106/ml 
of washed peritoneal cells obtained 4 h after administration of 0.1% glycogen were employed. The 
cells were allowed to  migrate  into  a  3  ~m pore  size Millipore filter for 80  min at  37°C.  For 
reversibility studies with both peptides, cells were incubated 30 min at 37°C in varying concentra- 
tions of a given peptide before washing with buffer or saline and testing in fresh medium. 
Induced Lysosomal Enzyme Secretion.  Washed neutrophils were resuspended to a  final con- 
centration of 1 ×  107/ml in Hanks' buffer containing 2 mg/ml of bovine serum albumin and 10/~g/ 
ml cytochalasin B (Aldrich Chemical Co., Milwaukee, Wis.). The cytochalasin B was diluted from 
The  Boyden chamber system measures enhanced migration due  to  either an  increase in 
random locomotion or in directed migration or both. As is shown later, the synthetic peptides we 
have studied stimulate both forms of movement. Therefore, in an attempt at greater terminologi- 
cal exactitude, in describing our experimental results, we have tried to use the noncommittal 
terms "enhanced migration," "stimulated movement," etc., except under circumstances where we 
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a stock solution containing  4 rng/rnl in dimethyl sulfoxide. The dimethyl sulfoxide remaining  after 
dilution  was  shown  not  to  affect  the  release  (5).  In  duplicate,  0.5  rnl  of  cell  suspension was  added  to 
0.5 rnl  of  fourfold  serial  dilutions  of  peptide  in 12 x 75 rnrn  test  tubes at  4°C.  The mixtures were 
then  incubated for  5  rnin  at  37°C (the  release  is  completed  in  I  rnin  or  less  under  these  conditions) 
and  the  tubes  centrifuged  at  2,500  rprn  (1,400g)  for  5  rnin  at  4°C.  The  supernates were  removed  and 
aliquots taken for measurement of lactic  dehydrogenase,  lysozyrne,  and /~-glucuronidase  as 
described  (5). 
The total  concentration  of  enzyme was  measured by  lysing  the  cells  with  buffer  containing 0.1% 
Triton X-100 (Beckrnann  Instruments, Inc.,  Fullerton,  Calif.).  The units  of  enzyme activity  were 
calculated  as described (4).  We measured the lactic  dehydrogenase of  each supernate to ensure 
that the peptides induced no release of  this  cytoplasmic marker. No release  was found in any 
instance. 
The ability  of each peptide to induce lysosomal enzyme release was assayed essentially  as 
described  for  chernotaxis.  The lysozyrne  or  fi-glucuronidase  activity  released  into  the supernate at 
each concentration  of  a given  peptide  plotted  against  the logarithm  of  the molar concentration  of 
the peptide  gave rise  to a sigrnoidal  dose-response  curve.  As with chernotaxis,  in  a given  experi- 
ment, the curves were parallel  in their  linear  portions and showed the same maximum. The 
lysosornal  enzyme-inducing  activity  for  each  peptide  was  obtained  from  the  dose-response  curve as 
its  E  D.~o,  the molar  concentration  of  peptide  causing 50%  of  the maximal release  of  either  lysozyrne 
or  fi-glucuronidase.  In  order  to  correct  for  changes  in  the  responsiveness  of  different  cells,  the  dose- 
response curve  of  the standard  peptide,  F-Met-Leu was  measured whenever any group  of  peptides 
was assayed  so that the activity  relative  to the standard could  be also  calculated. 
Synthesis of Peptides.  Leu-Trp-Met and Leu-Trp-Met-Arg were purchased from Research 
Plus,  Denville,  N. J.,  and  forrnylated  by  the  method  of  Sheehan and Yang (11).  All  other  synthetic 
peptides  used in  this  study  were prepared  by  the Merrifield  solid-phase  technique (12)  essentially 
as  described  by  Stewart  and Young (13).  Amino acid  resins  with  the  exception  of  rnethionine,  were 
prepared  by  the  reaction  of  the  triethylarnrnoniurn  salt  of  the  tert-butyloxycarbonyl  (t-Boc)  ~  amino 
acid  and the  chlorornethyl  resin  in  ethanol at  85°C for  24-65 h. The Met resin  was  prepared  by  the 
reaction  of  the  cesium  salt  of  t-Boc  methionine  in  dirnethylacetamide  for  18  h at  room  temperature 
according  to  the method  of  Gisin (14).  Subsequent  couplings  were  by  standard  solid-phase  methods 
using dicyclohexylcarbodiirnide.  Side-chain protecting  groups used in this  study were glutarnic 
acid  (benzyl)  and arginine (NO~).  The completed  peptides  were cleaved  from  the resin  by reaction 
with  liquid  hydrogen fluoride  (HF) for  30 rnin  at  0°C.  50 equivalents  of  anisole  were added to  the 
HF to provide a free  radical  scavenger. The HF-treated resin  was washed with ethyl  ether to 
remove anisole and its reaction products. The resin  was extracted with 1 M  acetic  acid  and 
lyophilized.  Some of  the synthetic  peptides were only sparingly soluble  in I M  acetic  acid  and 
therefore  it  was necessary to extract  them with glacial  acetic  acid. 
The synthetic  peptides  were purified  either  by countercurrent distribution  (100  transfers  in  n- 
butanol:  acetic  acid:  water;  4:1:5)  or  preparative  high  voltage  electrophoresis  (pyridine:  acetic  acid: 
water;  compounds were  considered  pure  if  they  showed  only one  spot  on  high  voltage  electrophore- 
sis at pH 5.0,  and in at least  two thin-layer  chromatography systems [usually  n-butanol:  acetic 
acid:  water, 4:1:5  or  cellulose  and  chloroform:  methanol: acetic  acid:  water,  65:30:4:1  on  silica  gel]). 
In all  cases  both ninhydrin and nonspecific  12  stains  were used to visualize  the peptides.  Amino 
acid  content was determined by quantitative  analysis  on a Beckman 121 C Amino Acid Analyzer 
(Beckman Instruments, Inc.). 
Forrnylated  rnethionyl  peptides  were  prepared  successfully  by  the method  of  Sheehan and Yang 
(10).  Unforrnylated peptides  were removed from the reaction  mixture by passage of  the peptide 
through Dowex 50 (Dow Chemical Co.,  Midland, Mich.).  Forrnylated  peptides  were subject  to  the 
same analytical  tests  and criteria  of  purity  described  for  the unforrnylated  peptides. 
All the peptides  studied  are L amino acid  peptides.  They are not so  designated in  what follows 
merely because of  convenience. 
Abbreviations used in this paper: HF, hydrogen fluoride; 5 HPF, five high-power fields; t-Boo, 
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TABLE I 
The Nature of the Migration of Neutrophils Induced by F-Met-Leu-Phe and F-Met-Met- 
Met 
Molar concentration above fil- 
ter 
Molar concentration below the filter 
1.85  x  5.55  x  1.66  x 
6.2 x  i0  -'~  5  x  i0-'" 
i0-"  I0-"  I0-'° 
A. F-Met-Leu-Phe 
6.2 x  i0  '~  29  46  [35]  64  [47] 
1.85  x  I0  -'i  40  70  [54] 
5.55  X 10-"  31  [55]  60 
1.66  ×  10 -'o  34  [67]  36  [67]  71 
5  ×  10  '"  49  [72]  47  [72]  46  [72]  73 
10-~  I0-~  i0-7  i0-~ 
75  [61] 
82  [64] 
66  [68] 
B. F-Met-Met-Met 
10-"  27  30  [27]  57  [30]  69  [35] 
10 -~  27  [30]  30  47  [30]  62  [35] 
10  -7  34  [33]  36  [34]  34  60  [38] 
I0  -~  38 [52]  34 [52]  48 [52]  56 
The unbracketed figures are the measured mean distance from the top of the filter to the front 
polymorphonuclear leukocytes (PMNs) in one plane of focus (40  x  objective). The figures within 
the diagonals are  the  measured mean distance in  a  uniform concentration of the  respective 
peptides. The latter are used to calculate the distances to the front two PMNs of a  hypothetical 
population undergoing purely random migration as described by Zigmond and Hirsch (8). These 
are the bracketed figures. 
Results 
Demonstration that the Synthetic Peptides are Chemotactic.  Increased pene- 
tration of cells into or through the filter of a Boyden chamber system under the 
stimulus of a  chemical agent is generally taken as indicating the chemotactic 
activity of the agent. Zigmond and Hirsch have pointed out that the increased 
migration could result from a response directed by the chemical gradient, that is 
from chemotaxis,  or  from increased  random  locomotion or  both  (10). These 
authors have described a technique for determining if the movement of the cell 
into the filter of a  Boyden chamber system under the influence of different 
gradients is greater than could be expected on the basis of increased rates of 
locomotion alone and to that extent is due to a true chemotactic response. Table 
I shows the results of tests of two representative synthetic peptides, F-Met-Leu- 
Phe and F-Met-Met-Met. In Table I, the unbracketed values are the experimen- 
tally determined distances into the filter that the front two cells of the popula- 
tion moved when various concentrations of either F-Met-Leu-Phe (A) or F-Met- 
Met-Met (B) were placed above and below the filter. The bracketed values are 
the predicted distances the front two cells would move in a random walk process 
in which the only variable was the rate of random locomotion. These values 
were determined, as described  (10), from the distance the cells moved in the 
absence of a gradient (values within the diagonal lines). The bracketed values 
thus represent the migration one would expect from cells that were not exhibit- 
ing chemotaxis, that is were moving by random locomotion alone. 1158  CHEMOTACTIC  AND  ENZYME-RELEASING  ACTIVITY  OF  PEP'rIDES 
400" 
<9 
o_ 
I  300- 
U 
~  200- 
u 
u 
I--- 
U 
0  ~oo. 
I 
u 
O- 
F-MET-LEU-PH~/~ 
/ 
/ 
\\\ III 
/  8  I 
¢ 
)-PHE 
F-MET 
/ 
/ 
/ 
/ 
/ 
,t 
lo-,°  lg-,  ,0-8  lo-,  ,0-°  ,0-5  ,o-,  ,o-3 
CONCENTRATION  (M/L) 
FIG.  1.  The assay of the migration inducing (chemotactic) activity of four peptides: F-Met- 
Leu-Phe (A---A), F-Met-Leu (A- A), Met-Leu-Phe (O---O), and F-Met-Leu-Glu (O-O). 
The overall results with both peptides were the same. Over the concentration 
ranges given in Table I, the effects of the two peptides on locomotion were rapid 
and  largely reversible  (results  not  shown).  Both peptides  stimulate  random 
movement of the  neutrophil as  shown  by the  penetration obtained  when  no 
gradient was present. Comparison of experimental values with predicted values 
shows that both peptides are also chemotactic. The cells moved significantly 
farther than predicted (greater than 10/zm) when the concentration of peptide 
below was greater than above the filter (positive gradient) and not as far as 
predicted when the reverse was the case (negative gradient). With each peptide, 
two additional experiments gave essentially the same result. 
Comparison  of the  Chemotactic Activities of the  Various Peptides.  Fig.  1 
shows the results of a  representative experiment in which the migration en- 
hancing activity of  four peptides were compared. In the experiment of Fig. 1, the 
EDso,~ of F-Met-Leu-Phe, F-Met-Leu, F-Met-Leu-Glu, and  Met-Leu-Phe were 
found to be, respectively, 4.1  x  10  -;~ M, 3.0  x  10  _7 M, 4.2  x  10  -7 M, and 1.3  × 
10-" M. Thus, for this experiment, F-Met-Leu-Phe was 7,300 times; F-Met-Leu- 
Glu, 0.71  times; and the Met-Leu-Phe, 0.43 times as active as F-Met-Leu. 
The chemotactic activity of the 24 peptides was determined as just described. 
In  every case,  the  activity of each peptide was  determined in at  least three SHOWELL  ET  AL.  1159 
TABLE  II 
Chemotactic Activity of Synthetic Peptides 
EDso -+ SE  Relative Activity* _  SE 
1. F-Met  2.1  _+ 0.62  ×  10  -3  0.0003  _+ 0.00017 
2.  F-Met-Leu  4.0 -+ 0.45  x  10  -7  1 
3.  F-Met-Leu-Phe  7.0 _+  1.7  ×  10-"  5,050  -+ 820 
4. F-Met-Leu-Glu  1.3 -+ 0.38  ×  10  -6  0.37  -  0.17 
5.  F-Met-Leu-Arg  3.6  _+  1 x  10 -7  0.98  -+ 0.11 
6.  F-Met-Leu-Leu  4.8  -  1.3  ×  10 -8  9.2  _+ 2.7 
7. F-Met-Phe  4.1  _+ 0.95  ×  10  -7  1.3 -+ 0.33 
8.  F-Met-Phe-Leu  5.4  -+ 1.9  ×  10  -s  10 --- 2.4 
9.  F-Met-Phe-Met  1.5  -+ 0.33  x  10  -9  169  -  50 
10. F-Met-Met  8.8  -+ 2.3  ×  10  -7  0.57  _+ 0.21 
11. F-Met-Met-Met  5.1  -+ 0.62  ×  10  -~  70 -+ 32 
12. F-Met-Met-Met-Met  3.0  -+ 0.13  ×  10 -~°  760 -+ 82 
13. F-Met-Met-Ala  5.4  _+ 1.8  ×  10  -7  1 -+ 0.3 
14. F-Met-Met-Phe  2.1  _+ 0.49  ×  10 -~°  1,900  _  260 
15. F-Leu-Trp-Met  2.5  _+  1.5  x  10 -s  17 -+ 5.6 
16. F-Leu-Trp-Met-Arg  1.1  -+ 0.4  x  10  -~  0.25  _+ 0.06 
17. Met-Leu-Phe  6.7  _  1.9  ×  10 -7  0.48  -  0.08 
18. Met-Leu-Glu  2.7  +__ 1.0  ×  10  -3  0.00017  _+ 0.00005 
19. Met-Leu-Leu  2.1  _+ 0.24  ×  10  -4  0.0015  -  0.0003 
20.  Met-Phe-Leu  2.4  _+  1.1  x  10 -4  0.003  --- 0.0015 
21.  Met-Met-Met  1.0 +_ 0.39  x  10  -4  0.003  -+ 0.0008 
22.  Met-Met-Met-Met  1.3  _+ 0.29  x  10 -~  0.19  -+ 0.06 
23. Met-Met-Ala  1.9 _+ 0.39  x  10  -4  0.003  -- 0.00008 
24.  Met-Met-Phe  9.0  -- 3.9  x  10  -7  0.7  -+ 0.29 
* Relative to F-Met-Leu  =  1.0. 
separate  experiments  similar  to the  one pictured  in Fig.  1.  The  results  of these 
experiments  are  compiled  in Table  II which  shows  the  mean  ED.~o  -  SE  (stand- 
ard  error)  and  the  mean  activity  _+  SE  of each  peptide  relative  to the  standard, 
F-Met-Leu. 
The  high  activity  attainable  and  the  wide  spread  in activities  of the  various 
peptides  are  clearly  evident;  the  mean  ED.~o of F-Met-Leu-Phe,  the  most  active 
peptide  tested  being  7.0  _  1.7  ×  10 -1~ M  and  the  least  active,  Met-Leu-Glu  is 2.7 
+  1.0  ×  10  -3  M,  a  26 million-fold  difference  in activity.  Another  way  of stating 
the  same  thing  is  that  the  F-Met-Leu-Phe  is  5,000-fold  more  active  than  the 
reference  compound,  F-Met-Leu,  whereas  Met-Leu-Glu  is  only  1.7  ×  10  -4  as 
active.  The  other  peptides  fall more  or less regularly  between  these  extremes. 
Inspection  of Table  II reveals  the  very  great  specificity  in the  relationship  of 
structure  to  activity,  small  structural  changes  being  capable  of creating  large 
differences  in  activity.  For  example,  F-Met-Leu-Phe  and  F-Met-Phe-Leu  differ 
only  in the  inversion  of the  terminal  two  amino  acids yet  F-Met-Leu-Phe  is 500 
times  more  active  than  F-Met-Phe-Leu.  Similarly,  F-Met-Met-Phe  is  approxi- 
mately  10 times  as  active  as  F-Met-Phe-Met. 
Moreover,  there  are  striking  regularities  in  the  relationship  of structure  to 
activity.  In confirmation  of the  report  of Schiffmann  et al.  (2),  the  presence  of a 
formyl  group  on  the  N-terminal  methionyl  residue  enhances  activity:  F-Met- 
Leu-Phe  is approximately  10,000-fold  more  active  than  the  corresponding  Met- 1160  CHEMOTACTIC  AND  ENZYME-RELEASING  ACTIVITY  OF  PEPTIDES 
Leu-Phe; F-Met-Phe-Leu is around 3,000-fold  more active than Met-Phe-Leu; 
and F-Met-Met-Met is approximately 20,000 times more active than Met-Met- 
Met. Among the dipeptides studied, addition to F-Met of a neutral amino acid, 
either methionine, leucine,  or  phenylalanine increased  activity to the  same 
extent,  approximately  3,000-fold.  Among  the  tripeptides  tested,  a  terminal 
phenylalanine had the most striking effect. F-Met-Leu-Phe is 5,000 times more 
active than F-Met-Leu, whereas F-Met-Leu-Leu is only 9 times as active. F-Met- 
Leu-Glu and F-Met-Leu-Arg are equal to or one-third as active as F-Met-Leu, 
respectively. This same large effect of terminal phenylalanine is seen in other 
tripeptides.  For example,  F-Met-Met-Phe is  approximately 3,500-4,000  times 
more  active than the parent dipeptide,  F-Met-Met;  addition of another me- 
thionyl residue to F-Met-Met to give F-Met-Met-Met increases activity only 120- 
to  150-fold.  Addition of an  alanine  residue  is  without effect, F-Met-Met-Ala 
having the same activity as F-Met-Met itself. 
As is also seen in Table II, increasing the number of  methionyl residues in the 
peptide chain progressively increases activity at least up to F-Met-Met-Met- 
Met. The increment in activity tends to be less with each methionine residue 
added suggesting that if  the series were to be continued, maximal activity might 
be attainable with a peptide containing only five or six methionyl residues. It is 
not clear at this time whether the effectiveness of the methionine in the series is 
due to its containing a sulfur atom or a hydrophobic side chain or both. 
Schiffmann et al. in their initial work suggested that N-acylated methionine 
is required for chemotactic activity (2). Table II shows that F-Leu-Trp-Met and 
F-Leu-Trp-Met-Arg are both active, the first with an EDso of 2.5  x  10 -8 M and 
the second with an ED~o of 1  x  10  -~ M.  These are not among the most active 
peptides obtained but indicate that there is no absolute requirement for an F- 
Met residue  for high  activity.  Moreover,  the  40-fold  drop  in  activity on the 
addition of basic  arginine residue to F-Leu-Trp-Met indicates that the great 
dependence of activity on structure extends to these peptides as well. 
Synthetic Peptides as Inducers  of Lysosomal Enzyme Secretion.  The pep- 
tides  listed  in  Table  II  were  also  tested for their  ability in the  presence  of 
cytochalasin B to induce the secretion of the lysosomal enzymes, fl-glucuroni- 
dase and lysozyme. Fig. 2, illustrates the results obtained in one experiment in 
which five peptides were tested for their ability to induce secretion of lysozyme 
and fl-glucuronidase. As already described, the dose-response curves were par- 
allel in their linear portion and showed the same maximum. From such curves, 
the ED.~o.s and relative activities were calculated. Each peptide was similarly 
assayed on at least three separate occasions. 
Table III gives for the entire group of 24 peptides the mean lysosomal enzyme- 
releasing activities _  SE relative to the activity of F-Met-Leu, as well as the 
mean ED.~o,s -+ SE. Five peptides, F-Met, Met-Leu-Glu, Met-Phe-Leu, Met-Met- 
Ala,  and  Met-Leu-Leu did  not induce release  of either lysosomal enzyme at 
concentrations of 1 ×  10 -~ M or higher. 
The structure activity relationships for the release of lysozyme or B-glucuroni- 
dase are the same and are also the same as that for chemotaxis. The last is 
shown in Figs. 3 and 4, where the logarithms of the ED~o,s for chemotaxis of 19 
peptides are plotted against the logarithm of the EDso,s for/3-glucuronidase (Fig. SHOWELL  ET  AL.  1161 
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Fro. 2. The  assay of the  ability of five peptides: F-Met-Met-Met (A--/x), F-Met-Leu 
(O--O), F-Met-Met (O---O), F-Met-Leu-Glu  (Q--O), and Met-Leu-Glu (&--A) to release 
B-glucuronidase (left-hand  frame) and lysozyme  (right-hand frame). 
3) or lysozyme (Fig. 4) release. The extremely close correlation between chemo- 
tactic activity and releasing ability for both enzymes is apparent. The correla- 
tion coefficients for chemotaxis and lysozyme secretion and for chemotaxis and 
B-glucuronidase  are  both  0.98.  These  very  high  correlations  extend  over  a 
greater than one million-fold range in activity. The linear regression equation 
relating the logarithm of the ED~, for lysozyme release (YL) to the logarithm of 
the ED~o for chemotaxis (X) is: 
YL =  (0.95  --  0.27)X  +  0.45. 
The corresponding equation relating the logarithm of the ED.~, for/3-glucuron- 
idase release (YG) to that for chemotaxis (X) is: 
YG  =  (0.97  _+  .30)X  +  0.67. 
The slopes of these equations are indistinguishable from 1, indicating that the 
enzyme-releasing and chemotactic activity of the peptides are linearly propor- 
tional to each other. 
Table III also shows that higher concentrations of peptide are required to give 
lysosomal enzyme release than a corresponding chemotactic response. The mean 
ratio  of the  EDso,s for enzyme release  to  the  ED~.  for chemotaxis for all  19 
peptides is 7.53  _+  1.17 for lysozyme and 9.29  _+  1.58 for B-glucuronidase. This 
says that on the average, rabbit neutrophils require approximately 7.5  times 1162  CHEMOTACTIC  AND  ENZYME-RELEASING  ACTIVITY  OF  PEPTIDES 
TABLE  HI 
Lysozomal Enzyme-Releasing Activity of Synthetic Peptides 
Lysozyme  B Glucuronidase 
ED,o ± SE  Relative±  sEaCtivity*  ED~  ± SE  Relative±  sEActivitY* 
1.  F-Met  >1  ×  10  -2  >0.00001  >1  x  10 -2  >0.00001 
2.  F-Met-Leu  1.7  ±  0,17  x  10  -~  1  1.9  ±  0.21  x  10  -6  1 
3.  F-Met-Leu-Phe  2.4  ±  0.31  x  10  -'°  5,120 ±  480  2.6  ±  0.32  x  10  -'°  4,470  ±  610 
4.  F-Met-Leu-Glu  5  ±  1.3  x  10  -~  0.24  ±  0.02  7.2  +- 0.29  x  10  -6  0.23  ±  0.02 
5. F-Met-Leu-Arg  2.2  ±  0.45  ×  10 -6  0.76  ±  0.05  2.6  ±  0.7  x  10 -6  0.72  ±  0.04 
6. F-Met-Leu-Leu  2.8  +_ 0.41  x  10  -7  6.9  ±  0.88  4.5 ±  2.1  x  10  -7  4.3  ±  0.7 
7.  F-Met-Phe  1.5  ±  0.39  ×  10  -6  0.99  ±  0.08  2  ±  0.42  x  10  -6  0.82  ±  0.06 
8.  F-Met-Phe-Leu  3.3  ±  0.7  x  10  -7  5.9  ±  1.1  3.5  ±  1.6  ×  10  -7  4.6  ±  1 
9.  F-Met-Phe-Met  2.6  -  0.5  x  10  -~  92  ±  14.7  3.5  ±  0.6  x  10 -8  77  ±  11 
10.  F-Met-Met  2.9  ±  0.47  x  10  -~  0.39  ±  0.06  7.5 ±  3.5  x  10  -6  0.28  ±  0.05 
11.  F-Met-Met-Met  4.3  ±  1.4  x  10  -~  41  ±  2.8  3.1  ±  0.63  x  10 -~  41.9 ±  10.6 
12.  F-Met-Met-Met-Met  2.4  ±  0.34  ×  10 -~  1,080  ±  340  3  ±  0.73  x  10  -~  980  ±  290 
13,  F-Met-Met-Ala  1.5  ±  0.5  ×  10  -~  2.3  -+  0.88  1.5  ±  0.45  x  10 -6  1.4  ±  0.15 
14,  F-Met-Met-Phe  1.9 ±  0.4  x  I0  -~  1,630  ±  260  1.8  ±  0.24  x  10  -~  1,380  ±  230 
15,  F-Leu-Trp-Met  5.7  ±  0.5  ×  10  -7  4.2  ±  1.4  7.3  ±  0.75  x  10 -7  3.6  ±  0.4 
16.  F-Leu-Trp-Met-Arg  1.1  ±  0.17  x  10 -~  0.16  ±  0.02  1.9  ±  0.55  x  10 -~  0.15  ±  0.03 
17,  Met-Leu-Phe  8.9  -+  1.4  ×  10  7  1.5  ±  0.11  9.7  ±  0.12  ×  10  -7  1.3  ±  0.17 
18.  Met-Leu-Glu  >5  ×  10 -:~  >0,0005  >5  ×  10  -3  >0.0005 
19,  Met-Leu-Leu  >1  x  10  -:~  >0.0001  >1  ×  10  -3  >0.0001 
20. Met-Phe-Leu  >I ×  I0  -~  >0.0001  >i x  i0  -,~  >0.0001 
21. Met-Met-Met  8.8 ± 4.4 ×  10  -4  0.004 ± 0.001  7.2 ±  1.3 ×  10  -4  0.0035 ± 0.001 
22. Met-Met-Met-Met  1.2 ± 0.19 × 10  -s  0.2 ± 0.03  1.7 ± 0.47 x 10  -~  0.17 ± 0.03 
23. Met-Met.Ala  >1 ×  10  -:~  >0.0001  >1 x  10  -:~  >0.0001 
24. Met-Met-Phe  8.9 ± 3.3 x 10  -~  0.41 ± 0.09  8 ±  1.2 x 10  -6  0.29 ± 0.08 
The mean lysozyme release as percent of total lysozyme  ±  standard deviation was 88  ±  19%; the mean fl glucuroni- 
dase release as percent of total/~-glucuronidase was 53  -+  7.0%. The mean total lysozyme activity ±  standard devia- 
tion from 107 neutrophils was 440  ±  180;  the mean total B-glucuronidase activity was  15  ±  3.3 ~g phenolphthalein 
released/h from 1  ×  107 neutrophils. 
* Relative to F-Met-Leu  =  1.0. 
more  peptide  for lysozyme release  than for migration enhancement and  9.3 
times more for ~-glucuronidase release. 
As one would expect from the curves of Fig. 3 and inspection of the data of 
Table III, there is also a close correlation between the ED.~o for fl-glucuronidase 
release and that for lysozyme. For all peptides, the mean ratio of the EDso for ~- 
glucuronidase to that for lysozyme is 1.26 +_ 0.095.  In other words, an approxi- 
mately 25% greater concentration of a given peptide is required to give 50% of 
maximal /~-glucuronidase secretion than is required for 50% of maximal lyso- 
zyme release. This difference is statistically significant. 
Discussion 
Agents  may  induce  cells  to  move  into  or  through  a  micropore  filter  by 
stimulating random or directed locomotion (chemotaxis) or both.  Substances 
that increase random locomotion but are not chemotactic have been reported by 
several workers (15-17).  Thus, in describing any substance as "chemotactic," on 
the basis of its ability to stimulate movement in a  Boyden chamber system, it 
becomes  essential  to  provide  evidence that,  in  fact,  the  agent is  capable  of 
inducing directed movement. The data of Table I demonstrate that two of the 
synthetic peptides studied here, F-Met-Leu-Phe and F-Met-Met-Met, not only 
increase random movement but also induce a true chemotactic response. More- SHOWELL  ET  AL.  1163 
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FIo.  3.  The relation between the migration inducing (chemotactic) activity of 19 peptides 
and their ability to induce B-glucuronidase release. F-Met-Leu (2), F-Met-Leu-Phe (3), F- 
Met-Leu-Glu (4), F-Met-Leu-Arg (5), F-Met-Leu-Leu (6), F-Met-Phe (7), F-Met-Phe-Leu (8), 
F-Met-Phe-Met (9), F-Met-Met [10), F-Met-Met-Met (ll), F-Met-Met-Met-Met (12), F-Met- 
Met-Ala (13), F-Met-Met-Phe (14), F-Leu-Trp-Met (15), F-Leu-Trp-Met-Arg (16), Met-Leu- 
Phe (17), Met-Met-Met (21), Met-Met-Met-Met (22), and Met-Met-Phe (24). 
over,  in  unpublished  work,  Zygmond has  confirmed  by  direct  morphologic 
observation that F-Met-Met-Met is chemotactic. It is reasonable to believe that 
these two peptides are representative of the other peptides and thus, that at 
least part  of the  movement induced by the  class of peptides  studied here  is 
directed locomotion, i.e., that these peptides are truly chemotactic. 
Certain of the peptides investigated are active at very low concentrations. F- 
Met-Leu-Phe,  the  most  active  compound  obtained  so  far,  has  an  ED~o for 
chemotaxis of 7 x  10  -~ M, and with suitable cells its activity is detectable at less 
than 1 x  10 -11 M. This can be contrasted with the activity of C5a, one of  the more 
potent natural chemotactic factors which in our hands is  active with rabbit 
neutrophils in the range of 10-7-10 -~ M.  Our chemotactic assay uses 2.5  ×  10" 
neutrophils in 1 ml. A value of 1 x  10  -~ M chemotactic peptide corresponds to 
approximately 2,400 molecules of peptide per neutrophil. What the concentra- 
tion would be at the leading edge of the gradient under these circumstances is 
not known but should be distinctly lower. These calculations not only demon- 
strate the very great activity of F-Met-Leu-Phe but suggest that for the most 
active obtainable peptide one molecule per cell might be sufficient. A program of 
synthesis to obtain such maximally active peptides is currently under way based 
on the structure-activity relationships revealed in this work. 
Not only are the synthetic peptides capable of high activity but the relation of 
structure  to  activity is  an  exceedingly specific  one,  very  small  changes  in 
structure making large changes in activity. Moreover, this specificity exhibits a 1164  CHEMOTACTIC  AND  ENZYME-RELEASING  ACTIVITY  OF  PEPTIDES 
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definite regularity and pattern; the activity of a given peptide depends not only 
on its  constituent  amino  acids  but  on the  place  of these  amino  acids in  the 
peptide chain.  This can be seen by considering the requirements for maximum 
chemotactic activity of a tripeptide of the general structure, A~A2A.~ as revealed 
by this study. 
From the work of Schiffmann et al. (2) and the work reported here, it is clear 
that for maximum activity the positively charged terminal amino group must be 
neutralized.  Moreover, the previous finding that N-formyl methionyl peptides 
are distinctly more active than N-acetyl methionyl peptides  (2) suggests that 
decreasing  the  bulk  of the  group  acylating  the N-terminal  amino  group  in- 
creases activity.  This  in turn  suggests that  deletion of the N-terminal  amino 
group might increase activity still more. This suggestion is in process of being 
tested. 
As mentioned,  methionine in the NH2-terminal position has been considered 
to be required for activity (2).  As shown here,  F-Leu-Trp-Met has reasonably 
high activity (ED.~o, 2.5  ×  10  -8 M) indicating that there is no absolute require- 
ment for methionine in this position. Moreover, F-Leu-Trp-Met and F-Met-Phe- 
Leu have essentially the same activity, the EDs0,s being 2.5 ×  10  -s M and 5.4 × 
10  -8 M, respectively. If one considers that phenylalanine and tryptophan in the 
second  position  are  equivalent  by virtue  of their  hydrophobic character  (see 
below), then the findings just alluded to suggest that it is the nonpolar character 
of methionine which is of importance in the NH2-terminal position. This is given 
some credence by the prior finding that F-leucine is chemotactic although not as 
active as F-methionine (2). If this suggestion is correct, then F-norleucine might SHOWELL  ET  AL.  1165 
serve as well or almost as well as F-methionine.  The test of this idea is now 
under way. 
The dipeptides F-Met-Leu, F-Met-Phe, and F-Met-Met all have essentially the 
same activity  (Table II).  The  positively charged  F-Met-His or the  negatively 
charged F-Met-Glu were found to be distinctly less active than F-Met-Leu (2). 
These findings suggest that in the second position of the peptide chain, a neutral 
amino  acid  with  a  sufficiently  nonpolar  side  chain  is  required  for  maximal 
activity. 
Although  any  neutral,  sufficiently  nonpolar  amino  acid  seems  to  confer 
maximum activity when in the second position, this does not seem to be the case 
for amino  acids in the third  position.  In  F-methionyl  tripeptides,  a  terminal 
phenylalanine,  seems to be particularly and peculiarly effective and this capac- 
ity does not seem to reside wholly in its hydrophobic character.  F-Met-Leu-Phe 
is  5,000  times  more  active  than  F-Met-Leu,  whereas  F-Met-Leu-Leu  with  a 
terminal nonpolar amino acid residue is only 9 times more active. Similarly, F- 
Met-Met-Phe is 3,400-4,400 times more active than F-Met-Met, whereas adding 
another  methionyl residue to form F-Met-Met Met increases activity only 125 
times and the activity of F-Met-Met-Ala is essentially the same as F-Met-Met. 
(Table I). In these tripeptides, if only the hydrophobic character of the terminal 
phenylalanine was the cause of their greatly increased activity one would expect 
F-Met-Leu-Leu and F-Met-Met-Met with their terminal hydrophobic side chains 
to approach the activity of F-Met-Leu-Phe and F-Met-Met-Phe; instead, they are 
30-500 times less active. 
Moreover, the striking effect of phenylalanine  is seen only when it is in the 
third position in the peptide chain; in the second position, it contributes nothing 
more to the activity than  do the other neutral  nonpolar amino acids studied. 
This is evident when phenylalanine is the terminal amino acid of a dipeptide, F- 
Met-Phe  having  the  same  activity  as  F-Met-Leu  and  F-Met-Met.  It  is  also 
evident when phenylalanine is present in the second position of a tripeptide; F- 
Met-Phe-Leu and F-Met-Phe-Met are 500 and 10 times less active, respectively, 
than  F-Met-Leu-Phe  and  F-Met-Met-Phe,  the  corresponding  tripeptides  with 
phenylalanine  in the third position. 
It is not known whether this specific effect of phenylalanine  in the terminal 
position of the tripeptide is due to its aromaticity or to its stereospecificity. Also 
it is not known whether the high activity of phenylalanine in the tripeptides is 
due to its being in the third position from the NH~-terminal end or because it is 
terminal. 
The findings just discussed are most simply explained and strongly support 
the hypothesis that the primary interaction of synthetic peptide and neutrophil 
leading to either chemotaxis or lysosomal enzyme release is the binding of the 
peptide to a stereospecific receptor on the neutrophil surface. This hypothesis is 
in accord with the great specificity of the structural  requirements  for activity 
and, even more, the manner in which the activity depends not only on the amino 
acids  present  but  also  on  their  position  in the  peptide  chain.  The  very low 
concentrations,  10-1°-10 TM  M at which the most highly active peptides work is 
compatible  with  an  extremely  firm  binding  of these  agents  to  the  putative 
neutrophil receptor, i.e., to the receptor-peptide association constant being quite 1166  CHEMOTACTIC  AND  ENZYME-RELEASING  ACTIVITY  OF  PEPTIDES 
high. The evidence for a  stereospecific receptor is indirect, but the work pre- 
sented here forms the basis for obtaining the requisite direct evidence. 
The suggestion has been made that nonpolar side chains are of key impor- 
tance  in  chemotactic recognition,  there  being  no  particular requirement for 
stereospecific binding (1). The importance of nonpolar side chains is seen in the 
requirement for acylation of the NI-I2-terminal group and for amino acids with a 
hydrophobic side chain in the first and in the second position of the peptide 
chain. However, other results with the chemotactic peptides are not in agree- 
ment with  the hypothesis that  only hydrophobicity is  of importance.  In the 
tripeptides  studied  here  a  terminal  phenylalanine contributes  more  to  the 
activity than can be described to its nonpolar character; in addition, the quanti- 
tative nature of the contribution of phenylalanine depends on its position in the 
peptide chain demonstrating that more is required for activity in these peptides 
than hydrophobicity. Moreover,  if it were merely a  matter of hydrophobicity 
there should be little or no difference in activity between N-formyl and N-acetyl 
methionyl peptides. On this same basis, one would expect F-Met-Phe-Leu to be 
as active as F-Met-Leu-Phe and F-Met-Phe-Met to be as active as F-Met-Met- 
Phe instead of them being, respectively, 500 and 10 times more active. 
A wide variety of agents are reported to be chemotactic, proteolytic enzymes, 
proteins, denatured proteins, polypeptides derived from complement (1), cyclic 
AMP, (19-21),  prostaglandins (22), and oxidized fatty acids (23). The chemotac- 
tic activity of some of these agents has been disputed (24) and for some, e.g. 
oxidized fatty acids, there is no present evidence of the type adduced in this 
paper,  that they are truly chemotactic. Thus, although our work clearly sug- 
gests the existence of a  stereospecific receptor for the peptides studied here it 
does not preclude the possibilities that there are other receptors for other agents 
or, as suggested by several authors (1,  18), that some of these agents may not 
require a  stereospecific binding to the neutrophil surface. The results of this 
study provide the means to decide among these and other possibilities. 
Wissler et al.  working with a  chemotactic binary peptide system have sug- 
gested that cellular recognition of chemotactic factors depends on the energy 
change as the factor goes from one conformation to another (24). The active 
peptides studied here are probably too small to have any large preferred confor- 
mation in solution suggesting either that the concept of Wissler et al. cannot be 
generally applicable  or that the putative conformational changes must occur 
after the peptide has bound to the surface. 
As pointed out in the introduction, previous work has shown that the same 
substance can induce both chemotaxis and lysosomal enzyme secretion from 
neutrophils (3-6).  The present work demonstrates an essentially exact correla- 
tion  between  the  chemotactic activity of these  synthetic peptides  and  their 
ability to induce lysosomal enzyme release over a  more than one million-fold 
range  in  activities  (Figs.  3  and  4).  This  implies  that  these  two  neutrophil 
functions are triggered by the same primary interaction; possibly, the binding of 
the peptides to the same putative neutrophil receptor. Both lysosomal enzyme 
release and chemotaxis are the result of  long sequences of  biochemical reactions, 
some parts of which must be different. This work although suggesting that the 
initial interaction is the same for chemote~is and lysosomal enzyme secretion SHOWELL  ET  AL.  1167 
throws no  light on how far beyond this primary reaction,  if at  all,  the  two 
functions share a common sequence. 
There  is  also  a  close  correlation between the  release  of lysozyme and the 
release of fl-glucuronidase, implying that the same initial interaction of  cell and 
peptide suffices to induce release of both enzymes. Approximately one-third of 
the  lysozyme of rabbit  neutrophils  comes  from  primary  granules,  and  the 
remainder from secondary granules (25). In many experiments, the peptides and 
cytochalasin B induced the release of almost 100% of the lysozyme, indicating 
that these peptides are capable of inducing release of this enzyme as well or 
almost as well, from primary as from secondary granules. Approximately 25% 
more peptide is required to release 50% of the total fl-glucuronidase than the 
same proportion of lysozyme, indicating that the release from the two types of 
granules is not rigidly coupled. This is seen more clearly in other experimental 
circumstances; the ratio of  the maximum percentage of  these same two enzymes 
released by bacterial chemotactic factor from rabbit neutrophils on filters in the 
absence of cytochalasin B can vary over a 20-fold range (reference 5; and H. J. 
Showell and E. L. Becker, unpublished observations) and Goldstein et al. have 
reported  that  Ca  .'+  can  release  a  high  proportion  of lysozyme from  human 
neutrophils with little or no release of/3-glucuronidase (26). 
In addition to chemotaxis and lysosomal enzyme release, a  third function of 
the neutrophil is phagocytosis. Chemotactic agents, including F-Met-Leu, are 
able to inhibit the initial rates of erythrophagocytosis by neutrophils in what 
appears to be a competitive fashion (27). There is also the unpublished evidence 
of Henson and Oades that C5a when on a particle enhances phagocytosis (28). 
One hypothesis is that the same initial interaction of chemotactic agent with cell 
is  not  only able  to  induce  chemotaxis and  lysosomal enzyme  secretion  but 
trigger phagocytosis as well. The availability of the series of synthetic peptides 
allows us to test this hypothesis. This test is now under way. 
Summary 
24 di-, tri-, and tetrapeptides have been synthesized as a start of a systematic 
study of the  structural  requirements for chemotactic activity and  lysosomal 
enzyme-releasing ability in rabbit neutrophils. All but two of  them are N-formyl 
methionyl peptides. 
Using the method of Zigmond and Hirsch (10), two representative peptides, F- 
Met-Leu-Phe and F-Met-Met-Met, were shown to stimulate directed, as well as, 
random locomotion; thus, they were truly chemotactic. The various peptides 
showed  a  wide  spread  in  activity.  F-Met-Leu-Phe,  the  most  active  peptide 
studied, had an ED.~o for induced migration of 7 ×  10-" M and for lysozyme and 
fl-glucuronidase release of 2.4  ×  10  -j'' M and 2.6  ×  10  -~° M, respectively; the 
least active, Met-Leu-Glu was 26 million times less active in these respects. The 
relation of activity to structure is exceedingly specific, very small changes in 
structure making large changes in activity. Moreover, this specificity exhibits a 
definite regularity and pattern; the activity of a given peptide depends not only 
on its constituent amino acids but on the position of the  amino acid  in the 
peptide chain. Most striking in this last regard is the high activity conferred by 
phenylalanine when  it  is  in  the  carboxyl  terminal  position  of a  tripeptide, 1168  CHEMOTACTIC  AND  ENZYME-RELEASING  ACTIVITY  OF  PEPTIDES 
whereas,  as  the  second  amino  acid from the  NH2  terminal  end  whether  in  a 
tripeptide or a dipeptide, it contributes no more to the activity than other amino 
acids with hydrophobic side chains such as leucine or methionine. 
The high  activity  and  the  specificity  and  nature  of the  structural  require- 
ments strongly suggest that the primary interaction of peptide and neutrophil 
leading  to  either  chemotaxis  or lysosomal enzyme release  is  a  binding  of the 
peptide  with  a  stereospecific receptor  on  the  neutrophil  surface.  Whether  all 
chemotactic factors act through the same receptor is not known. 
An  essentially  exact  correlation  exists  between  the  concentrations  of the 
various  synthetic  peptides  required  to  induce  migration  and  their  ability  to 
induce  release  of lysozyme  or  /~-glucuronidase.  This  implies  that  these  two 
neutrophil  functions  are  triggered  by the  same primary interaction;  possibly, 
the binding of the peptides to the same putative receptor.  A  higher concentra- 
tion of a given peptide is required to stimulate lysosomal enzyme release than a 
corresponding migratory response.  A  slightly but significantly higher  concen- 
tration of peptide is required to induce fl-glucuronidase secretion than lysozyme 
release. 
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